Viewing StudyNCT00519285



Ignite Creation Date: 2024-05-05 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00519285
Status: COMPLETED
Last Update Posted: 2016-07-22
First Post: 2007-08-21

Brief Title: Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
Sponsor: Sanofi
Organization: Sanofi

Organization Data

Organization: Sanofi
Class: INDUSTRY
Study ID: EFC6546
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Sanofi
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Regeneron Pharmaceuticals INDUSTRY